More about
High-Grade Tumors
News
January 22, 2025
3 min read
Save
Adding anthracyclines to taxane-based chemotherapy beneficial in high-risk breast cancer
SAN ANTONIO — The addition of anthracyclines to adjuvant taxane-based chemotherapy improved survival for certain high-risk patients with breast cancer, according to data presented at San Antonio Breast Cancer Symposium.